Summary
The possibility of pharmacokinetic interactions between Saiko-ka-ryukotsu-borei-to extract powder (TJ-12), a widely used traditional Chinese herbal (Kampo) medicine, and carbamazepine (CBZ), an important anti-epileptic drug, was examined in rats. There were no significant differences in the serum protein binding of CBZ and carbamazepine-10, 11-epoxide (CBZ-E), its active metabolite, at two concentrations (1 and 10 Bg/ml) between two groups pretreated orally with the vehicle and TJ-12 suspension (1 g/kg/d, p.o.) for 1 week. One-week repeated pretreatment with TJ-12 (1 g/kg/d) did not influence liver weight, contents of cytochromes P450 and b5 in hepatic microsomes or the formation rate of CBZ-E from CBZ by its microsomes, while pretreatment with phenobarbital (80 mg/kg/d, i.p.) significantly increased these paramenters. Neither a single nor 1-week repeated oral pretreatment with TJ-12 (1 g/kg/d) affected the plasma concentration-time profile and any pharmacokinetic parameter of CBZ or CBZ-E after oral administration of CBZ (50 mg/kg). These results indicated that oral co-administration of TJ-12 with CBZ has no effect of the pharmacokinetics of CBZ or CBZ-E in rats. Concomitant treatment with TJ-12 and CBZ appears to be pharmacokinetically safe in humans.
Similar content being viewed by others
References
Ohnishi N., Yonekawa Y., Fumihara T., Nakasako S., Nagasawa K., Yokoyama T., Yoshioka M., Kuroda K. (1999). Studies on interactions between traditional herbal and Western medicines. II. Lack of pharmacokinetic interaction between Sho-seiryu-to and carbamazepine in healthy volunteers. Jpn. J. TDM, 16, 399–404.
Iwai A., Sugiyama Y., Kawakami A., Ueno K. (1991). Effects of Saibokuto on theophylline disposition and laboratory findings. Jpn. J. TDM, 8, 57–64.
Hasegawa T., Yamaki K., Nadai M., Muraoka I., Wang L., Takagi K., Nabeshima T. (1994). Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers. Int. J. Clin. Pharmacol. Ther., 32, 57–61.
Hasegawa T., Yamaki K., Muraoka I., Nadai M., Takagi K., Nabeshima T. (1995). Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin. Antimicrob. Agents Chemother., 39, 2135–2137.
Homma M., Oka K., Ikeshima K., Takahashi N., Niitsuma T., Fukuda T., Itoh H. (1995). Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J. Pharm. Pharmacol., 47, 687–692.
Qi J., Toyoshima A., Honda Y., Mineshita S. (1997). Pharmacokinetic study on acetaminophen: interaction with a Chinese medicine. J. Med. Dent. Sci., 44, 31–35.
Uno T., Ohkubo T., Sugawara K., Higashiyama A., Motomura S. (1998). Effects of Shigyaku-san (TJ-35) on pharmacokinetics and pharmacodynamics of nicardipine. Iyakuhin-Sogosayo-Kenkyu, 21, 139–145.
Ohnishi N., Yonekawa Y., Nakasako S., Nagasawa K., Yokoyama T., Yoshioka M., Kuroda K. (1999). Studies on interactions between traditional herbal and Western medicines. III. Effects of Sho-seiryu-to on the pharmacokinetics of carbamazepine in rats. Biol. Pharm. Bull., 22, 527–531.
Sasaki K., Suzuki K., Yoshizaki F., Ando T. (1995). Effect of Saiko-karyukotsu-borei-to on the stress-induced increase of serum corticosterone in mice. Biol. Pharm. Bull., 18, 563–565.
Senzaki A., Okubo Y., Matsuura M., Kojima T., Toru M. (1993). Clinical studies on effects of Saiko-ka-ryukotsu-borei-to (TJ-12) for adult patients with symptomatic localization-related epilepsy. Rinsho-Seishin-Igaku, 22, 641–646.
Doumas B.T., Watson W.A., Biggs H.G. (1971). Albumin standards and the measurement of derum albumin with bromcresol green. Clin. Chim. Acta, 31, 87–96.
Omura T., Sato R. (1964). The carbon monooxide-binding pigment of liver microsomes. J. Biol. Pharmacol., 239, 2370–2378.
Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. (1951). Protein measurement with folin phenol reagent. J. Biol. Pharmacol., 193, 265–275.
Daniel W., Janczar L., Danek L., Legrum W., Netter K. (1992): Pharmacokinetic interaction between carbamazepine and neuroleptics after combined prolonged treatment in rats. Naunyn-Schmiedeberg’s Arch. Pharmacol., 345, 598–605.
Yamaoka K. (1984): Drug disposition analysis by microcomputers. Tokyo: Nankodo, 149–159.
Kimura M., Tanaka N., Kimura Y., Miyake K., Kitaura T., Fukuchi H. (1993): Pharmacokinetic interaction of zonisamide in rats. Effect of zonisamide on other antiepileptics. Biol. Pharm. Bull., 16, 722–725.
Chang S.-L., Levy R.H. (1986): Inhibitory effect of valproic acid on the disposition of carbamazepine and carbamazepine-10,11-epoxide in the rat, Drug Metab. Dispos., 14, 281–286.
Iijima O., Minematsu S., Maemura S., Waterson L. A., Gopinath C., Connick H. (1995): A single oral dose toxicity study and a 13-week repeated dose study with a 4-week recovery period of TSUMURA Saikoka-ryukotsu-borei-to (TJ-12) in rats. Jpn. Pharmacol. Ther., 23 (suppl.), S1739-S1753.
Kang J.-J., Wang H.-W., Liu T.-Y., Chen Y.-C., Ueng T.-H. (1997): Modulation of cytochrome P-450-dependent monooxygenases, glutathion and glutathione S-transferase in rat liver by geniposide from Gardenia jasminoides. Food Chem. Toxicol., 35, 957–965.
Turner P.V., Renton K.W. (1989): The interaction between carbamazepine and erythromycin. Can. J. Physiol. Pharmacol., 67, 582–586.
Faigle J.W., Feldmann K.F. (1995): 40 Carbamazepine, chemistry and biotransformation. In: Levy R.H., Mattson R.H., Meldrum B.S. (Eds) Antiepileptic drugs, 4th edn. New York: Raven Press, 499–513.
Shinoda M., Akita M., Hasegawa M., Nadai M., Hasegawa T., Nabeshima T. (1995): Pharmaceutical evaluation of carbamazepine suppositories in rats. Biol. Pharm. Bull., 18, 1289–1291.
Rowland M., Tozer T.N. (Eds) (1989): Clinical pharmacokinetics concepts and applications, 2nd edn. Philadelphia: Lea & Febiger, 148–176.
Mattson G.F., Mattson R.H., Cramer J.A. (1982): Interaction between valproic acid and carbamazepine: an in vitro study of protein binding. Ther. Drug Monit., 4, 181–184.
Lertratanangkoon K., Horning M.G. (1982): Metabolism of carbamazepine. Drug Metab. Dispos., 10, 1–10.
Ohnishi T., Yoneyama H., Hamamoto T., Ishida T., Takahara J., Ichikawa Y. (1996): Induction of cytochrome P-450-linked monooxygenase system in rat liver microsomes by Xiano-Chaihu-Tang. Am. J. Chin. Med., 14, 143–151.
Tamura M., Nose M., Kojima K., Mizukami H., Ogihara Y. (1998): Scientific Evaluation of Kampo (No. 12) Effect of long term administration of Sho-saiko-to on the induction of drug metabolic enzyme (cytochrome P450). J. Trad. Med., 15, 344–345.
Kerr B.M., Thummel K.E., Wurden C.J., Klein S.M., Kroetz D.L., Gonzalez F.J., Levy R.H. (1994): Human liver carbamazepine metabolism, role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem. Pharmacol., 47, 1969–1979.
Wilkinson G.R. (1996): Cytochrome P4503A (CYP3A) metabolism: Prediction of in vivo activity in humans. J. Pharmacokin. Biopharmaceut., 24, 475–490.
Panesar S.K., Bandiera S.M., Abbott F.S. (1996): Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochrome P450 in the rat. Drug Metab. Dispos., 24, 619–627.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohnishi, N., Nakasako, S., Okada, K. et al. Studies on interactions between traditional herbal and western medicines. IV: Lack of pharmacokinetic interactions between Saiko-ka-ryukotsu-borei-to and carbamazepine in rats. Eur. J. Drug Metab. Pharmacokinet. 26, 129–135 (2001). https://doi.org/10.1007/BF03190386
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03190386